To whom do the research findings apply?

Heart

Volumn 87, Issue 6, 2002, Pages 570-574

  Furberg, Curt D ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLOGY; CLINICAL TRIAL; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; MEDICAL RESEARCH; PRIORITY JOURNAL; REVIEW; SAFETY;

EID: 0036105595     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.87.6.570     Document Type: Review

References (17)

1. Influence of adherence to treatment and response of cholesterol on mortality in the Coronary Drug Project
2. Coronary artery surgery study (CASS): A randomized trial of coronary artery bypass surgery. Comparability of entry characteristics and survival in randomized patients and non-randomized patients meeting randomization criteria
3. Mortality in non-consenters in a post-myocardial infarction trial
4. The n-of-1 randomized controlled trial: Clinical usefulness. Our three-year experience
5. Relation of gemfibrozil treatment and lipid levels with major coronary events. VA-HIT: A randomized controlled trial
6. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial
7. Clinical implications of recent findings from the antihypertensive and lipid-lowering treatment to prevent hearth attack trial (ALLHAT) and other studies of hypertension
8. Incommunicable knowledge? Interpreting and applying the results of clinical trials and meta-analyses
9. A patient's attitude to the use of research evidence for guiding individual choices and decisions in health care
10. What fraction of hospital ulcer patients is eligible for prospective drug trials?
11. Underrepresentation of women in clinical drug trials
12. The challenge of minority recruitment in clinical trials for AIDS
13. Underrepresentation of patients 65 years of age or older in cancer-treatment trials
14. Valvular heart disease associated with fenfluramine-phentermine
15. FDA Public Health Advisory. Reports of valvular heart disease in patients receiving concomitant fenfluramine and phentermine
16. WSJ Survey